20. Hematology - DNB QUESTIONS

• Describe the evolutionary development of the hemoglobins from embryo to adult. Dec 2020; 5mrks; nel 21ed pg2504.
• Fetal hematopoiesis. Dec 2019; 4mrks; nel 21ed pg2500-2504.
• Hematopoietic growth factors Dec 2018; 5mrks; gupta 2ed pg1810.
• Describe fetal hemoglobins. Jun 2014; 3mrks; nel 21ed pg2504
• Diamond -Blackfan anemia-clinical features and treatment. Dec 2018; 5mrk; nel 21ed pg2510.
• Characteristic hematological features, laboratory findings and treatment of congenital hypoplastic anemia (Diamond Blackfan Anemia) Dec 2015; 3+3+4mrks; nel 21ed pg2510.
• a)Anemia of Prematurity. b)Treatment options for a 3 month old preterm who has Hb of 6 gm%. Dec 2015; 5+5mrks; nel 21ed pg2517.
• What is physiologic anemia of infancy? Discuss its etiology, characteristics and management. Dec 2012; 2+(2+4+2); nel 21ed pg2517.
• Pathophysiology of vit B12 and folate deficiency. Jun 2020; 5mrks; nel 21ed pg2517.
• Diagnosis and management in a child with megaloblastic anemia. Jun 2019; 5mrks; nel 21ed pg2518
• Differentials for microcytic hypochromic anemia. Dec 2018; 5mrks; nel 21ed pg2507.
• Prevention of iron deficiency anemia in children under 5 years of age. Jun 2018; 5mrks
• Outline the etiology of Iron deficiency in children. Describe the clinical features and approach to diagnosis of a child suspected to be having nutritional anemia. Jun 2013; 3+(2+5)mrks; nel 21ed pg2517-2525.
• Describe the relationship among the various hemoglobin's in first year of life and their implication in diagnosing hereditary hemoglobinopathies. Dec 2020; 5mrks; nel 21ed pg2541,2554.
• Management of transfusion dependant thalassemia. Dec 2020; 5 mrks; nel 21ed pg2256.
• Iron chelating agents in pediatric practice. Jun 2020, Jun 2019, Jun 2017; 5 mrks; nel 21ed pg2256.
• Precautions to be taken while transfusing hemolytic child. Jun 2019; 4mrks
• Counselling of antenatal mother who is already having thalassemia major child. Dec 2019; 4mrks
• Indications of spleenectomy in thalassemia. Dec 2018; 5mrks; nel 21ed pg2256.
• What are usual patterns of hb electrophoresis in beta thalassemia syndromes. Jun 2018; 4mrks
• Diagnosis & management of methemoglobinemia. Dec 2017; 4 mrks
• Advances in treatment of thalassemia major. Dec 2016, Dec 2014; 5mrks
• Discuss transfusion therapy for thalassemia major and long term follow up plan. Jun 2014; 4+3mrks; nel 21ed pg2256.
• Outline the long-term complications of thalassemia major. How will you monitor for such complications in a child with thalassemia major? Jun 2013; 5+5mrks; nel 21ed pg2256.
• Diagnosis and management of autoimmune hemolytic anemia. Jun 2015; 3mrks
• Discuss etiopathogenesis of autoimmune hemolytic anemia. How will you investigate? Dec 2012; 5+5mrks
• Pathophysiology of thrombophilia. Outline management of polycythemia. Jun 2016; 4+4mrks
• Evaluate the child with pancytopenia. Jun 2020; 5mrk
• Management of aplastic anemia. Jun 2019; 5mrks
• Aplastic anemia. Jun 2016; 5mrks
• Define pancytopenia. Enumerate common causes in children. How will you assess severity of acquired aplastic anemia in children? Dec 2011; 2+3+5mrks
• Indications of blood components therapy. Jun 2020; 5mrks
• Enumerate indications of platelet transfusion in pediatric practice. Jun 2019; 5mrks
• Transfusion associated hepatitis- diagnosis & management. Jun 2017; 6mrks
• Describe briefly risks associated with blood transfusion therapy. Dec 2013; 10mrks
• Role and function of platelet in physiology of hemostasis. Jun 2020; 5mrks
• What are components of hemostatic process? Illustrate the clotting cascade. Jun 2019; 5mrks
• What is etiopathogenesis of vit K deficiency in infancy? Diagrammatic representation of coagulation cascade. Jun 2017; 5+5mrks
• a) Differentiate a bleeding disorder from a clotting disorder. b) Investigation and treatment of a 2 year old boy presenting with spontaneous hemarthrosis. Dec 2016; 3+2+5mrks
• Draw the coagulation cascade. Describe the Hess capillary test and enumerate the screening tests for a bleeding and a clotting disorder. Jun 2014; 4+6mrks
• Prophylaxis program in hemophilia. Dec 2019; 4mrks
• Advances in treatment of hemophilia. Jun 2019; 5mrks
• Specific treatment of mild to moderate bleeding in Haemophilia A. Jun 2018; 5 mrks
• Factor replacement therapy in Hemophilia. Jun 2017; 5mrks
• Von willebrand disease. Jun 2020; 5mrks
• Mechanism of action, therapeutic usage, dosages and adverse effects in children of: a) Low molecular weight heparins b) Magnesium sulphate. Jun 2016; 5+5mrks
• a) Discuss the approach to a neonate with thrombocytopenia with specific reference to causes and investigations. b) Prophylaxis program in hemophilia. Dec 2019; 6+4mrks
• Management of 1st episode of ITP. Dec 2019; 5mrks
• Management of chronic ITP. Dec 2018; 5mrks
• Management of Immune Thrombocytopenic Purpura (ITP) in children. Jun 2017; 5mrks
• An 8 year old girl has presented with epistaxis, bleeding gum and ecchymotic patches over trunk. Her platelet count is 20,000/cumm. Discuss the differential diagnosis with specific clinico-investigative pointers. Plan the diagnostic work up for this child. Dec 2013; 5+5mrks
• Discuss the treatment options for acute ITP in a 14 year old girl child. Jun 2013; 10mrks
• List the causes of thrombocytopenia in a febrile child. How would you manage a child with fever, platelet count of 25,000/cumm and absolute neutrophil count of 450/cu.mm? Dec 2012; 4+6mrks
• Describe the diagnostic approach and management of a six year old child presenting with purpuric rash and pedal edema following an episode of acute diarrhoea. Dec 2011; 4+6mrks